Korean J Pain.
2026 Jan;39(1):144-146. 10.3344/kjp.25362.
Authors’ reply to the letter to the editor regarding “Low-dose naltrexone for fibromyalgia: a re-analysis suggests lower efficacy than previously reported”
- Affiliations
-
- 1Department of Medicine, Faculty of Medicine, Pelita Harapan University, Karawaci, Tangerang, Indonesia
- 2Department of Medicine, Washington University of Health and Science, Belize, Central America, USA
- 3Department of Internal Medicine, Faculty of Medicine, Pelita Harapan University, Karawaci, Tangerang, Indonesia
- KMID: 2575859
- DOI: http://doi.org/10.3344/kjp.25362
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Low-dose naltrexone for fibromyalgia: a re-analysis suggests lower efficacy than previously reported
- Authors’ response to comments on “Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis”
- Comments on “Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis”
- Corrigendum: Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis
- Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis
